THERIVA BIOLOGICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.42 USD | +0.12% |
|
+2.19% | -2.35% |
Chart calendar Theriva Biologics, Inc.
31be9.BIYvWTyILWX_rCrvCvKo-LSQBNPlfUNAPXKwPmC8LU0.YbUbPHLueAmI42u_ZJ_BtIKhTKmiRDA6WBSEchP3Ywh8zGg-Xdd6Vsabcw~298b5407cd774d84f4082dcf61f46dc9
Upcoming events on Theriva Biologics, Inc.
Past events on Theriva Biologics, Inc.
| 2024-03-25 08:30 am | Q4 2023 Earnings Call |
| 2024-03-25 08:00 am | Q4 2023 Earnings Release |
| 2024-03-19 | Benzinga Virtual Healthcare Summit |
| 2024-03-18 10:00 am | BioEurope Spring Conference |
| 2024-01-18 09:30 am | B. Riley Securities Oncology Conference - Fireside Chat |
| 2023-12-06 03:10 pm | Emerging Growth Conference |
| 2023-11-13 08:30 am | Q3 2023 Earnings Call |
| 2023-11-13 08:00 am | Q3 2023 Earnings Release |
| 2023-11-07 05:15 am | BIO Europe Conference |
| 2023-11-02 12:00 am | Emerging Growth Conference |
| 2023-10-23 08:00 am | Investor Meeting - Key Opinion Leader |
| 2023-10-22 06:00 am | European Society for Medical Oncology Congress |
| 2023-10-05 09:40 am | Emerging Growth Conference |
| 2023-08-08 08:30 am | Q2 2023 Earnings Call |
| 2023-08-08 08:00 am | Q2 2023 Earnings Release |
| 2023-05-11 08:30 am | Q1 2023 Earnings Call |
| 2023-05-11 08:00 am | Q1 2023 Earnings Release |
| 2023-04-17 06:00 am | European of Clinical Microbiology & Infectious Diseases Congress - Poster Number: (#P2280) |
| 2023-03-30 08:30 am | Q4 2022 Earnings Call |
| 2023-03-30 08:00 am | Q4 2022 Earnings Release |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -15,7 -16,3 3.92% | -10,2 -12,0 15.45% | -14,3 -12,4 -14.67% | -21,6 -19,7 -9.78% | -21,4 -21,9 2.13% | -28,6 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 0,00 - | -10,1 -12,0 15.51% | -14,3 -12,4 -14.66% | -21,1 -19,6 -7.65% | -20,0 -21,4 6.78% | -28,6 |
|
Net income Million USD | Released Forecast Spread | -16,1 -16,9 4.87% | -12,6 -12,9 2.3% | -23,2 -12,4 -86.35% | -19,7 -19,6 -0.39% | -18,3 -21,4 14.43% | -28,6 |
|
EPS USD | Released Forecast Spread | -9,80 -10,3 4.85% | -6,60 -5,60 -17.86% | -1,90 -1,80 -5.56% | -1,31 -1,30 -0.77% | -1,14 -1,37 16.79% | -0,81 |
| Announcement Date | 20/02/20 | 04/03/21 | 16/03/22 | 30/03/23 | 25/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -5,27 -3,44 -53.1% | -4,99 -4,80 -3.8% | -5,01 -6,42 21.96% | -7,33 -5,41 -35.55% | -5,18 -6,23 16.83% | -5,82 -5,47 -6.34% | -4,22 -6,40 34.11% | -6,22 -6,68 6.95% | -6,57 | -6,86 | -7,43 | -7,72 | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -5,26 -3,44 -53.04% | -4,97 -5,11 2.68% | -4,85 -5,35 9.27% | -7,02 -5,52 -27.22% | -4,81 -6,23 22.78% | -5,44 -5,70 4.44% | -3,83 -6,40 40.17% | -5,91 -7,36 19.74% | -6,57 | -6,86 | -7,43 | -7,72 | |
|
Net income Million USD | Released Forecast Spread | -5,26 -3,44 -53.04% | -4,97 -5,11 2.68% | -4,85 -5,35 9.27% | -5,59 -5,52 -1.38% | -4,48 -6,23 28.08% | -5,08 -5,70 10.74% | -3,30 -6,40 48.41% | -5,49 -7,36 25.5% | -6,57 | -6,86 | -7,43 | -7,72 | |
|
EPS USD | Released Forecast Spread | -0,40 -0,30 -33.33% | -0,31 -0,40 22.5% | -0,33 -0,34 2.94% | -0,36 -0,35 -2.86% | -0,30 -0,39 23.08% | -0,34 -0,38 10.53% | -0,19 -0,42 54.76% | -0,33 -0,49 32.65% | -0,19 | -0,19 | -0,21 | -0,22 | |
| Announcement Date | 16/03/22 | 16/05/22 | 11/08/22 | 10/11/22 | 30/03/23 | 11/05/23 | 08/08/23 | 13/11/23 | 25/03/24 | - | - | - | - |
| Today 04:05 pm | EXELIXIS, INC.: Q1 2024 Earnings Release |
| 2024-04-30 | SUMMIT THERAPEUTICS INC.: Q1 2024 Earnings Release |
| 2024-04-30 | MACROGENICS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | REGENXBIO INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | DECIPHERA PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-01 07:00 am | NEUROCRINE BIOSCIENCES, INC.: Q1 2024 Earnings Release |
| 2024-05-01 04:05 pm | SAREPTA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-01 | ZENTALIS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-01 | DENALI THERAPEUTICS INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-01 | GERON CORPORATION: Q1 2024 Earnings Release |
Past sector events for Theriva Biologics, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- TOVX Stock
- Calendar Theriva Biologics, Inc.
